New York State Common Retirement Fund decreased its holdings in Amdocs Limited (NASDAQ:DOX - Free Report) by 15.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 461,674 shares of the technology company's stock after selling 87,100 shares during the period. New York State Common Retirement Fund owned 0.41% of Amdocs worth $42,243,000 at the end of the most recent reporting period.
Other hedge funds also recently bought and sold shares of the company. Axxcess Wealth Management LLC increased its position in Amdocs by 5.4% during the 4th quarter. Axxcess Wealth Management LLC now owns 2,431 shares of the technology company's stock valued at $207,000 after purchasing an additional 124 shares during the period. Farther Finance Advisors LLC grew its position in Amdocs by 17.5% during the 1st quarter. Farther Finance Advisors LLC now owns 988 shares of the technology company's stock valued at $90,000 after purchasing an additional 147 shares during the last quarter. Tower Research Capital LLC TRC boosted its holdings in shares of Amdocs by 55.0% during the 4th quarter. Tower Research Capital LLC TRC now owns 586 shares of the technology company's stock valued at $50,000 after acquiring an additional 208 shares during the last quarter. Allworth Financial LP boosted its holdings in shares of Amdocs by 13.2% during the 1st quarter. Allworth Financial LP now owns 1,829 shares of the technology company's stock valued at $157,000 after acquiring an additional 213 shares during the last quarter. Finally, Fifth Third Bancorp boosted its holdings in shares of Amdocs by 3.1% during the 1st quarter. Fifth Third Bancorp now owns 7,537 shares of the technology company's stock valued at $690,000 after acquiring an additional 225 shares during the last quarter. Hedge funds and other institutional investors own 92.02% of the company's stock.
Analyst Ratings Changes
Several brokerages have recently weighed in on DOX. Wall Street Zen upgraded shares of Amdocs from a "hold" rating to a "buy" rating in a research note on Saturday, June 7th. Wolfe Research initiated coverage on shares of Amdocs in a report on Tuesday, July 8th. They issued an "outperform" rating for the company. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has a consensus rating of "Buy" and an average price target of $105.33.
Check Out Our Latest Analysis on Amdocs
Amdocs Stock Up 0.1%
Amdocs stock traded up $0.13 during trading hours on Friday, reaching $89.44. The stock had a trading volume of 230,145 shares, compared to its average volume of 662,637. The company has a market cap of $10.10 billion, a price-to-earnings ratio of 18.84, a PEG ratio of 1.47 and a beta of 0.52. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.16 and a quick ratio of 1.16. The business's 50 day moving average price is $91.56 and its 200-day moving average price is $88.37. Amdocs Limited has a 52 week low of $78.61 and a 52 week high of $95.41.
Amdocs (NASDAQ:DOX - Get Free Report) last announced its earnings results on Wednesday, May 7th. The technology company reported $1.78 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.07. Amdocs had a net margin of 11.39% and a return on equity of 19.52%. The business had revenue of $1.13 billion during the quarter, compared to the consensus estimate of $1.12 billion. During the same period in the previous year, the company posted $1.56 earnings per share. The firm's revenue was down 9.4% on a year-over-year basis. Sell-side analysts anticipate that Amdocs Limited will post 6.21 EPS for the current year.
Amdocs Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Monday, June 30th will be paid a dividend of $0.527 per share. The ex-dividend date is Monday, June 30th. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.36%. Amdocs's payout ratio is 44.42%.
About Amdocs
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
See Also
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
